A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
Clinical trial NCT01328626 · COMPLETED
Trial details
- NCT number
- NCT01328626
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-23
- Primary completion
- 2020-05-08
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.